Lubbe
Andreas Lubbe, Paderborn DE
Patent application number | Description | Published |
---|---|---|
20110054237 | Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets - Systems and methods are disclosed for trapping or focusing magnetizable particles comprising therapeutic agents at a distance using a dynamic magnetic field and feedback control, to enable the treatment of diseased areas deep inside a patient's body. The methods may be used to diagnose or treat diseased areas deep within a patient, for example tumors of the lungs, intestines, and liver, and is also useful in enhancing the permeability of solid tumors to chemotherapeutic agents. | 03-03-2011 |
Carl Hermanus Lubbe, Charleston, WV US
Patent application number | Description | Published |
---|---|---|
20110041718 | SYSTEMS AND METHODS FOR CHEMICAL AND/OR MECHANICAL REMEDIATION OF NITRO COMPOUNDS AND NITRATE ESTERS - Systems and methods for chemoremediation or mechanical destruction of undetonated explosive materials. An explosive apparatus contains an explosive material in close proximity to a chemical reagent selected for its chemoremediative properties. A barrier is interposed between the explosive material and the chemical reagent to delay the chemoremediation of the explosive material. | 02-24-2011 |
20120180915 | EXPLOSIVE EMULSION COMPOSITIONS AND METHODS OF MAKING THE SAME - A detonator sensitive explosive emulsion composition includes an oxidizing phase including a supersaturated solution of ammonium nitrate and a fuel phase including sufficient emulsifying agent to permit dispersion of the oxidizing phase in the fuel phase. The detonator sensitive explosive emulsion composition further includes a crystallization temperature depressant consisting essentially of at least one of an amine and an amine nitrate. | 07-19-2012 |
Christoph Lubbe, Bruchsol DE
Patent application number | Description | Published |
---|---|---|
20080306752 | Method and system for automatic testing in a business scenario environment - A software tool for automatically executing relevant testing in an Application Platform. When an object in an Application Platform is changed, testing may be executed for the changed object as well as any related objects. | 12-11-2008 |
20090144721 | SYSTEM AND METHOD FOR PROVIDING SOFTWARE UPGRADES - A method and system provide a business scenario. The method includes executing a first deployment unit on a first application platform. The method includes replacing an original second deployment with an upgraded second deployment unit on an upgraded second application platform. The method includes executing the upgraded second deployment unit. The method including transmitting messages related to the business scenario over a communications link between the first deployment unit and the upgraded second deployment unit. The method includes storing master data related to the business scenario in a data storage. | 06-04-2009 |
Leon Lubbe, Potchefstroom ZA
Patent application number | Description | Published |
---|---|---|
20100044280 | Flotation Process Using an Organometallic Complex as Activator - The invention provides a flotation process which includes the steps of providing a flotation mixture containing mineral values to be recovered and adding an activator to the flotation mixture, which activator may comprise a metal complex formed by a coordinating metal ion and a ligand. A particular aspect of the invention relates to the use of the metal complexes as activators. These complexes are stable over a wide pH range, which is not the case with other inorganic compounds of which the applicant is aware, such as zinc sulphate, copper sulphate and manganese sulphate. The ligand may have the structure R—(X) | 02-25-2010 |
Markus Lubbe, Ast DE
Patent application number | Description | Published |
---|---|---|
20100291261 | CONTINUOUS BREWING PROCESS - A method for continuously producing wort as well as a method for carrying out said method, wherein order to optimize process times and avoid energy peaks, at least one of the processes for producing wort is continuously carried out at a substantially constant output. | 11-18-2010 |
Mathias Lubbe, Dresden DE
Patent application number | Description | Published |
---|---|---|
20150152066 | BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF IN CANCER THERAPY - The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy. | 06-04-2015 |
Pieter W. Lubbe, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20130068772 | CONTAINER LID WITH DETACHABLE CHAMBER OR COMPARTMENT - A lid for a container is adapted in its lower region for releasable attachment to the upper rim of the container. The lid has a detachable chamber or compartment which is located below the top surface of lid and depends downwardly therefrom, so that the detachable chamber or compartment is releasably secured to the lid in a position which is inaccessible when the lid is releasably connected to a container. Thus, any contents within the detachable chamber or compartment are only accessible when the lid has been detached from the container, and the detachable chamber or compartment has been removed from its securement to the lid. | 03-21-2013 |
Steven R. Lubbe, Washington Crossing, PA US
Patent application number | Description | Published |
---|---|---|
20130164420 | Natural Sweetener And Method Of Making - A natural sweetening composition comprising a plant based natural high intensity sweetening compound, molasses, and a carrier/substrate. | 06-27-2013 |
Wilhelm Lubbe, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20120308583 | USE OF GCC LIGANDS - Proliferation of colorectal, gastric and esophageal cancer cells is inhibited by administering ST receptor ligand. The number of ST receptor molecules on the surface of a colorectal cell or metastasized colorectal cancer cell are increased by administering an ST receptor ligand such that ligand comes into contact with an ST receptor on the surface of the colorectal cell. Pharmaceutical compositions comprise sterile, pyrogen free ST receptor ligand and a pharmaceutically acceptable carrier or diluent. Metastasized colorectal cancer is treated or imaged by increasing the number of ST receptor molecules on the surface of a metastasized colorectal cancer cell and then administering a pharmaceutical composition containing components that target the ST receptor for delivery of a therapeutic agent or imaging agent. Methods of detecting metastasized colorectal cancer are disclosed. Methods of delivering active compounds to a colorectal cell in an individual are disclosed. | 12-06-2012 |